Altered Pulmonary Blood Volume Distribution as a Biomarker for Predicting Outcomes in COVID-19 Disease

被引：0
|
作者：
Morris, M. [1 ]
Yash, P. [2 ]
Kang, P. [3 ]
Ridenour, L. [1 ]
Lavon, B. [4 ]
Lanclus, M. [5 ]
Gerzon, R. [6 ]
Gordon, R. [5 ]
De Backer, J. [4 ]
Csete, M. K. Glassberg [7 ]
机构：
[1] Banner Univ, Med Ctr, Phoenix, AZ USA
[2] Stanford Univ, Palo Alto, CA 94304 USA
[3] Univ Arizona, Phoenix, AZ USA
[4] Fluidda, New York, NY USA
[5] Fluiida, New York, NY USA
[6] Maasstad Ziekenhuis, Pediat, Rotterdam, Netherlands
[7] Univ Arizona, Coll Med Phoenix, Internal Med, Phoenix, AZ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3792
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Altered pulmonary blood volume distribution as a biomarker for predicting outcomes in COVID-19 disease
    Morris, Michael F.
    Pershad, Yash
    Kang, Paul
    Ridenour, Lauren
    Lavon, Ben
    Lanclus, Maarten
    Godon, Rik
    De Backer, Jan
    Glassberg, Marilyn K.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (03)
  • [2] Predicting covid-19 outcomes
    Habib, Anand R.
    Lo, Nathan C.
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 376
  • [3] Predicting Severe Outcomes in COVID-19
    Lipworth, Brian
    Chan, Rory
    Kuo, Chris R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08): : 2582 - 2584
  • [4] Predicting acute pulmonary embolism in COVID-19
    Koc, Ibrahim
    Deniz, Olgun
    Ozmen, Sevda Unalli
    Bulut, Sertan
    MEDICINE, 2023, 102 (34) : E34916
  • [5] The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study
    Zheng, Yufen
    Zhang, Ying
    Chi, Hongbo
    Chen, Shiyong
    Peng, Minfei
    Luo, Lifei
    Chen, Linping
    Li, Jun
    Shen, Bo
    Wang, Donglian
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (07) : 1106 - 1115
  • [6] The significance of a novel inflammatory biomarker, presepsin, in predicting disease prognosis in patients with COVID-19
    Karacaer, C.
    Sert, H.
    Demirci, T.
    Varim, C.
    Kaya, G.
    Genc, A. B.
    Cekic, D.
    Ergenc, H.
    Ergenc, Z.
    Yaylaci, S.
    Nalbant, A.
    Kaya, T.
    Demirci, A.
    Oztop, K. E.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (22) : 8612 - 8619
  • [7] Galectin-3 as a Novel Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients
    Baykiz, Derya
    Emet, Samim
    Ayduk-Govdeli, Elif
    Kaytaz, Murat
    Yavuz, Mustafa L.
    Karaca-Ozer, Pelin
    Karaayvaz, Ekrem B.
    Medetalibeyoglu, Alpay
    Elitok, Ali
    Genc, Sema
    Bugra, Zehra
    Umman, Berrin
    CLINICAL LABORATORY, 2022, 68 (12) : 2483 - 2495
  • [8] Predicting coronavirus disease (COVID-19) outcomes in the United States early in the epidemic
    Simoes, Eduardo J.
    Schmaltz, Chester L.
    Jackson-Thompson, Jeannette
    PREVENTIVE MEDICINE REPORTS, 2021, 24
  • [9] Physical phenotype of blood cells is altered in COVID-19
    Kubankova, Marketa
    Hohberger, Bettina
    Hoffmanns, Jakob
    Fuerst, Julia
    Herrmann, Martin
    Guck, Jochen
    Kraeter, Martin
    BIOPHYSICAL JOURNAL, 2021, 120 (14) : 2838 - 2847
  • [10] Outcomes of Pulmonary Rehabilitation for Patients With COVID-19
    Aljazeeri, J.
    Almusally, R.
    Wert, Y.
    Abdelhalim, M.
    Klinger, C.
    Rahman, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
12345